Fig. 1From: Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohortStudy flow diagram depicting the presence or absence of hearing loss, by severity, in patients treated for MDR-TBBack to article page